Enzymatica Publ (Sweden) Analysis
| ENZY Stock | SEK 1.80 0.06 3.45% |
Enzymatica publ AB is overvalued with Real Value of 1.61 and Hype Value of 1.8. The main objective of Enzymatica Publ stock analysis is to determine its intrinsic value, which is an estimate of what Enzymatica publ AB is worth, separate from its market price. There are two main types of Enzymatica Publ's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Enzymatica Publ's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Enzymatica Publ's stock to identify patterns and trends that may indicate its future price movements.
The Enzymatica Publ stock is traded in Sweden on Stockholm Exchange, with the market opening at 09:00:00 and closing at 17:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Sweden. Enzymatica Publ is usually not traded on NationalDay, International Workers ' Day, St . John 's Day, All Saints ' Day, Christmas Eve, Christmas Day, Boxing Day, New Year 's Day, Epiphany, Good Friday, Easter Sunday, Easter Monday. Enzymatica Stock trading window is adjusted to Europe/Stockholm timezone.
Enzymatica |
Enzymatica Stock Analysis Notes
About 64.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.37. Enzymatica publ AB had not issued any dividends in recent years. The entity had 2761:2760 split on the 5th of August 2022. Enzymatica AB, a life science company, develops and sells medical devices for infection-related diseases in Sweden and internationally. Enzymatica AB was incorporated in 2007 and is based in Lund, Sweden. Enzymatica operates under Pharmaceuticals And Biosciences classification in Sweden and is traded on Stockholm Stock Exchange. It employs 24 people. To learn more about Enzymatica publ AB call Fredrik Lindberg at 46 4 62 86 31 00 or check out https://www.enzymatica.se.Enzymatica publ AB Investment Alerts
| Enzymatica publ AB generated a negative expected return over the last 90 days | |
| Enzymatica publ AB may become a speculative penny stock | |
| Enzymatica publ AB has high historical volatility and very poor performance | |
| The company reported the revenue of 57.24 M. Net Loss for the year was (45.39 M) with profit before overhead, payroll, taxes, and interest of 33.35 M. | |
| Enzymatica publ AB has accumulated about 64.82 M in cash with (35.87 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.44. | |
| Roughly 64.0% of the company shares are held by company insiders |
Enzymatica Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 681.8 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Enzymatica Publ's market, we take the total number of its shares issued and multiply it by Enzymatica Publ's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Enzymatica Profitablity
Enzymatica Publ's profitability indicators refer to fundamental financial ratios that showcase Enzymatica Publ's ability to generate income relative to its revenue or operating costs. If, let's say, Enzymatica Publ is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Enzymatica Publ's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Enzymatica Publ's profitability requires more research than a typical breakdown of Enzymatica Publ's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (1.12) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.12) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.12. Technical Drivers
As of the 23rd of November, Enzymatica Publ shows the Standard Deviation of 4.78, variance of 22.82, and Mean Deviation of 2.87. Enzymatica publ AB technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.Enzymatica publ AB Price Movement Analysis
The output start index for this execution was two with a total number of output elements of fifty-nine. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Enzymatica Publ middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Enzymatica publ AB. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Enzymatica Publ Outstanding Bonds
Enzymatica Publ issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Enzymatica publ AB uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Enzymatica bonds can be classified according to their maturity, which is the date when Enzymatica publ AB has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Enzymatica Publ Predictive Daily Indicators
Enzymatica Publ intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Enzymatica Publ stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Enzymatica Publ Forecast Models
Enzymatica Publ's time-series forecasting models are one of many Enzymatica Publ's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Enzymatica Publ's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Enzymatica Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Enzymatica Publ prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Enzymatica shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Enzymatica Publ. By using and applying Enzymatica Stock analysis, traders can create a robust methodology for identifying Enzymatica entry and exit points for their positions.
Enzymatica AB, a life science company, develops and sells medical devices for infection-related diseases in Sweden and internationally. Enzymatica AB was incorporated in 2007 and is based in Lund, Sweden. Enzymatica operates under Pharmaceuticals And Biosciences classification in Sweden and is traded on Stockholm Stock Exchange. It employs 24 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Enzymatica Publ to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Analyst Advice Now
Analyst AdviceAnalyst recommendations and target price estimates broken down by several categories |
| All Next | Launch Module |
Additional Tools for Enzymatica Stock Analysis
When running Enzymatica Publ's price analysis, check to measure Enzymatica Publ's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enzymatica Publ is operating at the current time. Most of Enzymatica Publ's value examination focuses on studying past and present price action to predict the probability of Enzymatica Publ's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enzymatica Publ's price. Additionally, you may evaluate how the addition of Enzymatica Publ to your portfolios can decrease your overall portfolio volatility.